<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>Huang Lab â€” Home</title>
  <link rel="stylesheet" href="style.css"> <!-- æ‰€æœ‰æ ·å¼éƒ½æ”¾åˆ°è¿™é‡Œ -->

</head>
<body>
  <header>
    <h1>Huang Lab</h1>
    <h2 class="subtitle">Development and disease (leukemia and pediatric cancer)</h2>
    <nav>
      <a href="#home">ğŸ  Home</a> |
      <a href="xin.huang.html">ğŸ‘©ğŸ»â€ğŸ’» Xin Huang</a> |
      <a href="news.html">ğŸ“° News</a> |
      <a href="team.html">ğŸ‘¥ Team</a> |
      <a href="publications.html">ğŸ“š Publications</a> |
      <a href="resources.html">ğŸ§ª Resources</a> |
      <a href="#contact">âœ‰ï¸ Contact</a>
    </nav>
  </header>

  <div class="content-container">
    <!-- å·¦è¾¹ä¸»è¦å†…å®¹ -->
    <div class="main-content">
      <section id="home">
        <h2>Research Summary</h2>
        <p>
          Dr. Xin Huangâ€™s research focuses on developmental biology and its dysregulation in diseases such as leukemia and pediatric solid tumors, aiming to elucidate underlying mechanisms and develop new targeted therapeutic strategies. 
        </p>

        <p>
          By integrating multidisciplinary approaches including single-cell multi-omics, biophysics, cell and molecular biology, her work has identified and mechanistically validated novel tumor targets and combination therapies to overcome drug resistance, facilitating multiple national and international clinical translational studies.
        </p>

        <p>
          As first or corresponding author, Dr. Huang has published in journals such as <em>Cancer Cell</em>, <em>Developmental Cell</em>, <em>Nature Communications</em>, <em>JBC</em>, and <em>STAR Protocols</em>. Her research has been covered by leading domestic and international media outlets, including ScienceDaily and BioArt.
        </p>

        <p>
          The Huang Lab currently focuses on:
        </p>
        <ul>
          <li>
            Leveraging integrated â€œwetâ€ and â€œdryâ€ approaches with clinical tumor cohorts to identify and functionally characterize drug targets related to developmental stage, clonal heterogeneity, and the tumor microenvironment, thereby providing new strategies for diagnosis and clinical translation of therapies.</li>
          <li>
            Collaborating in frontier areas such as stem cell epigenetics, cell-fate determination, and translational research.</li>
        </ul>
        <div id="home-figure">
          <img src="images/CancerCell-HuangX.png" alt="Lab research overview">
        </div>
      </section>
    </div>

    <!-- å³è¾¹ä¾§æ  -->
    <aside class="sidebar">
      <section class="collaborators">
        <h2>Collaborators</h2>
        <ul>
          <li><a href="https://huangxinlab.github.io/zhulab.github.io/" target="_blank">Dr. Zhexin Zhu</a></li>
        </ul>
      </section>

      <section class="links">
        <h2>Links</h2>
        <ul>
          <li><a href="https://github.com/HuangXinLab" target="_blank">GitHub</a></li>
          <li><a href="https://scholar.google.com/citations?user=T-4h97gAAAAJ&hl=en" target="_blank">Google Scholar</a></li>
          <li><a href="http://icr.shgh.cn/rctd_show.aspx?id=32" target="_blank">Homepage</a></li>
        </ul>
      </section>

      <section id="contact">
        <h2>Contact</h2>
        <p>Email: xin.huang@sjtu.edu.cn</p>
      </section>
    </aside>
  </div>

  <footer>
    <p>&copy; 2025 Huang Lab. All rights reserved.</p>
  </footer>
</body>
</html>
